MyChesCo on MSN7h
FDA Approves Crenessity for Treating Classic Congenital Adrenal Hyperplasia
The U.S. Food and Drug Administration (FDA) has approved Crenessity (crinecerfont) for use alongside glucocorticoids in ...
Medscape16h
‘Game Changer’ Approved for Congenital Adrenal Hyperplasia
The US Food and Drug Administration has approved crinecerfont for treating congenital CAH in combination with glucocorticoids ...
clinicaladvisor.com1d
Crenessity Approved for Classic Congenital Adrenal Hyperplasia
The approval was based on phase 3 data from the randomized, double-blind, placebo-controlled CAHtalyst adult study and CAHtalyst pediatric study.
BioWorld1d
Neurocrine’s hyperplasia drug approved by the FDA
While Spruce Biosciences Inc.’s tildacerfont missed its phase II primary endpoint in classic congenital adrenal hyperplasia (CAH) last March, the U.S. FDA has now approved Crenessity (crinecerfont) ...
Endocrine Surgeons Discusses Thyroid, Parathyroid, and Adrenal Care
Endocrine surgeons primarily focus on the thyroid, parathyroid, and adrenal glands. For the thyroid, their work often ...